SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P5
Near historical low
vs 2Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -49.34% |
| Q3 2025 | 1097.73% |
| Q2 2025 | -43.88% |
| Q1 2025 | -17.83% |
| Q4 2024 | -29.65% |
| Q3 2024 | -20.02% |
| Q2 2024 | -12.81% |
| Q1 2024 | -40.88% |
| Q4 2023 | 232.12% |
| Q3 2023 | -25.56% |
| Q2 2023 | -19.24% |
| Q1 2023 | -21.45% |
| Q4 2022 | -13.39% |
| Q3 2022 | -17.56% |
| Q2 2022 | -9.80% |
| Q1 2022 | 7.92% |
| Q4 2021 | 9.90% |
| Q3 2021 | -8.31% |
| Q2 2021 | -65.03% |
| Q1 2021 | 180.43% |
| Q4 2020 | 0.00% |